Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université Laval

$116,000.00

Mechanisms of endocytosis and transcytosis into endothelial cells of the blood-brain barrier

FY 2024-25

Summary
OVERVIEW: The overall aim of the present program is to provide a much needed understanding of how the body communicates with the brain. More specifically, we will decipher the mechanisms underlying the endocytosis and intra-/intercellular trafficking of bioactive molecules circulating in the bloodstream and interacting with transporters/receptors located at the blood-brain barrier (BBB). BACKGROUND: It remains unclear to which extent large endogenous blood-borne substrates, like transferrin, undergo endocytosis, amass in endosomes and lysosomes, or are ferried across the BBB into the brain (transcytosis). One thing that is certain is that circulating compounds have to interact first with receptors expressed on the luminal side of brain microvessel endothelial cells (BMECs), forming the BBB. However, subsequent cellular routes and molecular mechanisms involved remain elusive. RECENT PROGRESS: In the last years, our group has developed a research platform with all the tools to accurately and quantitatively monitor compounds inside BMECs and in other brain cells, by combining in vitro and in vivo approaches with high-resolution technology. SPECIFIC OBJECTIVES: The subcellular fate of endogenous (substrates) or exogenous (monoclonal antibodies) ligands of vascular endothelial growth factor receptor 2 (VEGFR2), insulin-like growth factor 2 receptor (IGF2R) and ephrin type-A receptor 2 (ePHA2) will be determined after binding to their receptor in cultured BMEC. Mechanisms will be probed using changes in temperature and various inhibitors of endocytic pathways. Technical approaches will combine binding studies and immunofluorescence. Cellular and subcellular distribution and colocalization analyses will be performed with super-resolution STED fluorescence microscopy and scanning electron microscopy. Confirmatory experiments using quantitative and qualitative methods will be performed in vivo, using in situ cerebral perfusion in mice and intravenous injections. NOVELTY: The novelty of our general approach stems from the combination of quantitative and qualitative methodologies using both in vitro and in vivo studies and high-resolution technology. Consistent results from different receptor-mediated systems, with complementary methods, will strengthen each other to decipher endocytic molecular pathways. CONCLUSION: The main deliverables of the present grant application will be (i) the formation of graduate students with training on techniques pertaining to cellular transport mechanisms in the BBB, which are available in just a few laboratories in the world, (ii) the consolidation of a research platform for BMEC-internalizing ligands, (iii) a better understanding of endocytic mechanisms within BMECs triggered upon ligand binding to receptors and their impact on BBB function and brain homeostasis.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2020-04182
Name nom
Calon, Frederic
Department département
Pharmacy
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
116000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Mechanisms of endocytosis and transcytosis into endothelial cells of the blood-brain barrier
Keywords
brain endothelial cells; endocytosis; transferrin receptor; vegf receptor; blood--brain barrier; subcellular trafficking; monoclonal antibodies; receptor-mediated transport; student training; endosomal/lysosomal pathways
Application summary
OVERVIEW: The overall aim of the present program is to provide a much needed understanding of how the body communicates with the brain. More specifically, we will decipher the mechanisms underlying the endocytosis and intra-/intercellular trafficking of bioactive molecules circulating in the bloodstream and interacting with transporters/receptors located at the blood-brain barrier (BBB). BACKGROUND: It remains unclear to which extent large endogenous blood-borne substrates, like transferrin, undergo endocytosis, amass in endosomes and lysosomes, or are ferried across the BBB into the brain (transcytosis). One thing that is certain is that circulating compounds have to interact first with receptors expressed on the luminal side of brain microvessel endothelial cells (BMECs), forming the BBB. However, subsequent cellular routes and molecular mechanisms involved remain elusive. RECENT PROGRESS: In the last years, our group has developed a research platform with all the tools to accurately and quantitatively monitor compounds inside BMECs and in other brain cells, by combining in vitro and in vivo approaches with high-resolution technology. SPECIFIC OBJECTIVES: The subcellular fate of endogenous (substrates) or exogenous (monoclonal antibodies) ligands of vascular endothelial growth factor receptor 2 (VEGFR2), insulin-like growth factor 2 receptor (IGF2R) and ephrin type-A receptor 2 (ePHA2) will be determined after binding to their receptor in cultured BMEC. Mechanisms will be probed using changes in temperature and various inhibitors of endocytic pathways. Technical approaches will combine binding studies and immunofluorescence. Cellular and subcellular distribution and colocalization analyses will be performed with super-resolution STED fluorescence microscopy and scanning electron microscopy. Confirmatory experiments using quantitative and qualitative methods will be performed in vivo, using in situ cerebral perfusion in mice and intravenous injections. NOVELTY: The novelty of our general approach stems from the combination of quantitative and qualitative methodologies using both in vitro and in vivo studies and high-resolution technology. Consistent results from different receptor-mediated systems, with complementary methods, will strengthen each other to decipher endocytic molecular pathways. CONCLUSION: The main deliverables of the present grant application will be (i) the formation of graduate students with training on techniques pertaining to cellular transport mechanisms in the BBB, which are available in just a few laboratories in the world, (ii) the consolidation of a research platform for BMEC-internalizing ligands, (iii) a better understanding of endocytic mechanisms within BMECs triggered upon ligand binding to receptors and their impact on BBB function and brain homeostasis.
Université Laval - $116,000 Grant (2024-25) | Canada Spends